Lishui Country People's Hospital   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Lishui China (1937)

Organization Overview

First Clinical Trial
2017
NCT02971345
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Lishui Country People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Hepatocellular (Phase 3)

Neoplasms (Phase 1)

Stroke (Phase 4)

Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8